Precancerous and non-cancer disease endpoints of chronic arsenic exposure: The level of chromosomal damage and XRCC3 T241M polymorphism

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 706, Issue 1-2, 2011, Pages 7-12

  Kundu, Manjari ^a   Ghosh, Pritha ^a   Mitra, Sanhita ^a   Das, J K ^b   Sau, T J ^c   Banerjee, Saptarshi ^d   States, J Christopher ^e   Giri, Ashok K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b West Bank Hospital   (India)

^c MEDICAL COLLEGE AND HOSPITAL   (India)

^d VIVEKANANDA INSTITUTE OF MEDICAL SCIENCES   (India)

^e University of Louisville School of Medicine   (United States)

Author keywords

Arsenic susceptibility; Chromosomal instability; Neuropathy; Respiratory diseases; XRCC3 T241M polymorphism

Indexed keywords

ARSENIC; METHIONINE; THREONINE; XRCC3 PROTEIN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; CHROMOSOME DAMAGE; CONJUNCTIVITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EYE DISEASE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HOMOLOGOUS RECOMBINATION; HUMAN; INDIA; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SKIN DEFECT;

ADULT; ALLELES; AMINO ACID SUBSTITUTION; ARSENIC; CARCINOGENS; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; CONJUNCTIVITIS; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; METHIONINE; MUTAGENS; ODDS RATIO; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYMORPHISM, GENETIC; PRECANCEROUS CONDITIONS; SKIN DISEASES; THREONINE; WATER POLLUTANTS, CHEMICAL;

EID: 78650416827     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2010.10.004     Document Type: Article

References (53)

1. Chakraborti D., Das B., Rahman M.M., Chowdhury U.K., Biswas B., Goswami A.B., Nayak B., Pal A., Sengupta M.K., Ahamed S., Hossain A., Basu G., Roychowdhury T., Das D. Status of groundwater arsenic contamination in the state of West Bengal, India: a 20-year study report. Mol. Nutr. Food Res. 2009, 53:542-551.
2. Chen C.J., Chuang Y.C., You S.L., Lin T.M., Wu H.Y. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br. J. Cancer 1986, 53:399-405.
3. Hopenhayn-Rich C., Biggs M.L., Smith A.H. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int. J. Epidemiol. 1998, 27:561-569.
4. Smith A.H., Goycolea M., Haque R., Biggs M.L. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 1998, 147:660-669.
5. Schwartz R.A., Janniger C.K. Bowenoid papulosis. J. Am. Acad. Dermatol. 1991, 24:261-264.
6. Rahman M.M., Mandal B.K., Chowdhury T.R., Sengupta M.K., Chowdhury U.K., Lodh D., Chanda C.R., Basu G.K., Mukherjee S.C., Saha K.C., Chakraborti D. Arsenic groundwater contamination and sufferings of people in North 24-Parganas, one of the nine arsenic affected districts of West Bengal, India. J. Environ. Sci. Health A. Tox. Hazard. Subst. Environ. Eng. 2003, 38:25-59.
7. IARC, Some Drinking Water Disinfectants and Contaminants, Including Arsenic, IARC Monogr. Eval. Carcinog. Risks Hum. 84 (2004) 1-477.
8. Benramdane L., Accominotti M., Fanton L., Malicier D., Vallon J.J. Arsenic speciation in human organs following fatal arsenic trioxide poisoning-a case report. Clin. Chem. 1999, 145:301-306.
9. Mazumder D.N., Haque R., Ghosh N., De B.K., Santra A., Chakraborti D., Smith A.H. Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. Int. J. Epidemiol. 2000, 29:1047-1052.
10. Mukherjee S.C., Rahman M.M., Chowdhury U.K., Sengupta M.K., Lodh D., Chanda C.R., Saha K.C., Chakraborti D. Neuropathy in arsenic toxicity from groundwater arsenic contamination in West Bengal, India. J. Environ. Sci. Health. A. Tox. Hazard. Subst. Environ. Eng. 2003, 38:165-183.
11. Guha Mazumder D.N. Arsenic and non-malignant lung disease. J. Environ. Sci. Health. A. Tox. Hazard. Subst. Environ. Eng. 2007, 42:1859-1867.
12. Hossain M.K., Khan M.M., Alam M.A., Chowdhury A.K., Delwar H.M., Feroze A.M., Kobayashi K., Sakauchi F., Mori M. Manifestation of arsenicosis patients and factors determining the duration of arsenic symptoms in Bangladesh. Toxicol. Appl. Pharmacol. 2005, 208:78-86.
13. Baidya K., Raj A., Mondal L., Bhaduri G., Todani A. Persistent conjunctivitis associated with drinking arsenic contaminated water. J. Ocul. Pharmacol. Ther. 2006, 22:208-211.
14. Ghosh P., Banerjee M., De Chaudhuri S., Chowdhury R., Das J.K., Mukherjee A., Sarkar A.K., Mondal L., Baidya K., Sau T.J., Banerjee A., Basu A., Chaudhuri K., Ray K., Giri A.K. Comparison of health effects between individuals with and without skin lesions in the population exposed to arsenic through drinking water in West Bengal, India. J. Expo. Sci. Environ. Epidemiol. 2007, 17:215-223.
15. Kitchin K.T. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 2001, 172:249-261.
16. Wakamatsu T.H., Dogru M., Tsubota K. Tearful relations: oxidative stress, inflammation and eye diseases. Arq. Bras. Oftalmol. 2008, 71:72-79.
17. Collins A.R., Ma A.G., Duthie S.J. The kinetics of repair of oxidative DNA damage (strand breaks and oxidized pyrimidines) in human cells. Mutat. Res. 1995, 336:69-72.
18. van Gent D.C., Hoeijmakers J.H., Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat. Rev. Genet. 2001, 2:196-206.
19. Christmann M., Tomicic M.T., Roos W.P., Kaina B. Mechanisms of human DNA repair: an update. Toxicology 2003, 193:3-34.
20. Mahata J., Basu A., Ghoshal S., Sarkar J.N., Roy A.K., Poddar G., Nandy A.K., Banerjee A., Ray K., Natarajan A.T., Nilsson R., Giri A.K. Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat. Res. 2003, 534:133-143.
21. Basu A., Ghosh P., Das J.K., Banerjee A., Ray K., Giri A.K. Micronucleias biomarkers of carcinogen exposure in populations exposed to arsenic through drinking water in West Bengal, India: a comparative study in three cell types. Cancer Epidemiol. Biomarkers Prev. 2004, 13:820-827.
22. Ghosh P., Basu A., Mahata J., Basu S., Sengupta M., Das J.K., Mukherjee A., Sarkar A.K., Mondal L., Ray K., Giri A.K. Cytogenetic damage and genetic variants in the individuals susceptible to arsenic-induced cancer through drinking water. Int. J. Cancer 2006, 118:2470-2478.
23. Andrew A.S., Karagas M.R., Hamilton J.W. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. Int. J. Cancer 2003, 104:263-268.
24. Taylor B.F., McNeely S.C., Miller H.L., States J.C. Arsenite-induced mitotic death involves stress response and is independent of tubulin polymerization. Toxicol. Appl. Pharmacol. 2008, 230:235-246.
25. Banerjee M., Sarma N., Biswas R., Roy J., Mukherjee A., Giri A.K. DNA repair deficiency leads to susceptibility to develop arsenic-induced premalignant skin lesions. Int. J. Cancer 2008, 123:283-287.
26. Brenneman M.A., Wagener B.M., Miller C.A., Allen C.P., Nickoloff J.A. XRCC3 controls the fidelity of homologous recombinational repair: roles for XRCC3 in late stages of recombination. Mol. Cell 2002, 10:387-395.
27. Masson J.Y., Tarsounas M.C., Stasiak A.Z., Stasiak A., Shah R., Mcllwraith M.J., Benson F.E., West S.C. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev. 2001, 24:3296-3307.
28. Au W.W., Salama S.A., Sierra-Torres C.H. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ. Health Perspect. 2003, 111:1843-1850.
29. Lindh A.R., Rafii S., Schultz N., Cox A., Helleday T. Mitotic defects in XRCC3 variants T241M and D213N and their relation to cancer susceptibility. Hum. Mol. Genet. 2006, 15:1217-1224.
30. De Chaudhuri S., Ghosh P., Sarma N., Majumdar P., Sau T.J., Basu S., Roychoudhury S., Ray K., Giri A.K. Genetic variants associated with arsenic susceptibility: study of purine nucleoside phosphorylase, arsenic (+3) methyltransferase, and glutathione S-transferase omega genes. Environ. Health Perspect. 2008, 116:501-505.
31. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Press, Cold Spring Harbor, NY. 2nd ed.
32. Rasmussen R.E., Menzel D.B. Variation in arsenic-induced sister chromatid exchange in human lymphocytes and lymphoblastoid cell lines. Mutat. Res. 1997, 386:299-306.
33. Lee J.J., Trizna Z., Hsu T.C., Spitz M.R., Hong W.K. A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay. Cancer. Epidemiol. Biomarkers. Prev. 1996, 12:353-358.
34. Kannaar R., Hoeijimakers J.H., van Gent D. Molecular mechanisms of DNA double-stranded repair. Trends Cell Biol. 1998, 8:483-489.
35. Bishop D., Ear U., Bhattacharyya A., Calderone C., Beckett M., Weichselbaum R. XRCC3 is required for assembly of Rad51 complexes in vivo. J. Biol. Chem. 1998, 273:21482-21488.
36. Griffin C.S. Aneuploidy, centrosome activity and chromosome instability in cells deficient in homologous recombination repair. Mutat. Res. 2002, 504:149-155.
37. Shen M.R., Jones I.M., Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998, 58:604-608.
38. Savas S., Kim D.Y., Ahmad M.F., Shariff M., Ozcelik H. Identifying functional genetic variants in DNA repair pathway using protein conservation analysis. Cancer Epidemiol. Biomarkers Prev. 2004, 13:801-807.
39. Winsey S.L., Haldar N.A., Marsh H.P., Bunce M., Marshall S.E., Harris A.L., Wojnarowska F., Welsh K.I. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res. 2000, 60:5612-5616.
40. Matullo G., Guarrera S., Carturan S., Peluso M., Malaveille C., Davico L., Piazza A., Vineis P. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int. J. Cancer 2001, 92:562-567.
41. Andrew A.S., Karagas M.R., Nelson H.H., Guarrera S., Polidoro S., Gamberini S., Sacerdote C., Moore J.H., Kelsey K.T., Demidenko E., Vineis P., Matullo G. DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Hum. Hered. 2007, 65:105-118.
42. Kuschel B., Auranen A., McBride S., Novik K.L., Antoniou A., Lipscombe J.M., Day N.E., Easton D.F., Ponder B.A., Pharoah P.D., Dunning A. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum. Mol. Genet. 2002, 11:1399-1407.
43. Figueiredo J.C., Knight J.A., Briollais L., Andrulis I.L., Ozcelik H. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol. Biomarkers Prev. 2004, 13:5835-5891.
44. Shen H., Wang X., Hu Z., Zhang Z., Xu Y., Hu X., Guo J., Wei Q. Polymorphisms of DNA repair gene XRCC3 Thr241Met and risk of gastric cancer in a Chinese population. Cancer Lett. 2003, 206:51-58.
45. Shen M., Lan Q., Zhang L., Chanock S., Li G., Vermeulen R., Rappaport S.M., Guo W., Hayes R.B., Linet M., Yin S., Yeager M., Welch R., Forrest M.S., Rothman N., Smith M.T. Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity. Carcinogenesis 2006, 27:2083-2089.
46. Hu J.J., Smith T.R., Miller M.S., Mohrenweiser H.W., Golden A., Case L.D. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 2001, 22:917-922.
47. Han S., Zhang H.T., Wang Z., Xie Y., Tang R., Mao Y., Li Y. DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies. Eur. J. Hum. Genet. 2006, 14:1136-1144.
48. Thirumaran R.K., Bermejo J.L., Rudnai P., Gurzau E., Koppova K., Goessler W., Vahter M., Leonardi G.S., Clemens F., Fletcher T., Hemminki K., Kumar R. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis 2006, 27:1676-1681.
49. Han J., Colditz G.A., Samson L.D., Hunter D.J. Polymorphisms in DNA double-strand break repair genes and skin cancer risk. Cancer. Res. 2004, 64:3009-3013.
50. Ryk C., Kumar R., Thirumaran R.K., Hou S.M. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers. Lung Cancer 2006, 54:285-292.
51. Saccà S.C., Pascotto A., Camicione P., Capris P., Izzotti A. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch. Ophthalmol. 2005, 123:458-463.
52. Araujo F.D., Pierce A.J., Stark J.M., Jasin M. Variant XRCC3 implicated in cancer is functional in homology-directed repair of double-strand breaks. Oncogene 2002, 21:4176-4180.
53. Banerjee N., Banerjee M., Ganguly S., Bandyopadhyay S., Das J.K., Bandyopadhay A., Chatterjee M., Giri A.K. Arsenic-induced mitochondrial instability leading to programmed cell death in the exposed individuals. Toxicology 2008, 246:101-111.